Urinary 6-Sulfatoxymelatonin Excretion in Hyperandrogenic Women: The Effect of Cyproterone Acetate-Ethinyl Estradiol Treatment

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 2, 2004, Pages 102-107

  Luboshitzky, R ^a   Herer, P ^b   Shen Orr, Z ^c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Androgens; Cyproterone acetate; Estradiol; Melatonin; Polycystic ovary syndrome

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; DIANE; FOLLITROPIN; LUTEINIZING HORMONE; MELATONIN; PRASTERONE SULFATE; TESTOSTERONE;

ADRENAL HYPERPLASIA; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HORMONE SYNTHESIS; HUMAN; HYPERANDROGENISM; HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; TREATMENT OUTCOME;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROGEN ANTAGONISTS; CASE-CONTROL STUDIES; CYPROTERONE ACETATE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; MELATONIN; POLYCYSTIC OVARY SYNDROME;

EID: 1842459282     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815765     Document Type: Article

References (42)

1. Blaicher W, Imhof MH, Gruber DM, Schneberger C, Sator MO, Huber JC. Endocrinological disorders focusing on melatonin interactions. Gynecol Obstet Invest 1999; 48: 179-182
2. Bojkowski CJ, Arendt J. Factors influencing 6-sulphatoxymelatonin - a major melatonin metabolite in normal human subjects. Clin Endocrinol 1990; 33: 435-444
3. Brosen K. Drug interactions and the cytochrome P450 system. The role of cytochrome P4501A2. Clin Pharamacol 1995; 29: 20-25
4. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987; 64: 865-867
5. Brzezinski A, Lynch HJ, Seibel NM, Deng MH, Wurtman RJ. The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women. J Clin Endocrinol Metab 1988; 66: 891-895
6. Caglayan S, Ozata M, Ozisik G, Turan M, Bolu F, Ontenli C, Arslan N, Erbil K, Gul D, Ozdemir IC. Plasma melatonin concentration before and during testosterone replacement in Klinefelter's syndrome: Relation to hepatic indolamine metabolism and sympathoadrenal activity. J Clin Endocrinol Metab 2001; 86: 738-743
7. Cardinali DP, Nagle CA, Rosner JM. Control of estrogen and androgen receptors in the rat pineal gland by catecholamine transmitter. Life Sci 1975; 16: 93-106
8. Cardinali DP, Vacas MI, Keller-Sarmiento MI, Etchegogen GS, Pereyra EN, Chalayan HE. Neuroendocrine integrative mechanisms in mammalian pineal gland: effect of steroid and adenohypophyseal hormones on melatonin synthesis in vitro. J Steroid Biochem 1987; 27: 565-571
9. Delfs TM, Baarks S, Fock C, Schumacher M, Olcese J, Zimmerman RC. Sex steroids do not alter melatonin secretion in humans. Hum Reprod 1994; 9: 49-54
10. Falsetti L, Gaubera A, Tisi G. Efficacy of the combination ethinyl estradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovary syndrome. Hum Reprod 2001; 16: 36-42
11. Fruzetti F, Bersi C, Parrini D, Ricci C, Genazzani AR. Treatment of hirsutism: comparisons between different antiandrogen with central and peripheral effects. Fertil Steril 1999; 71: 445-451
12. Itoh MT, Ishizuka B, Kudo Y, Fusama S, Amemiya A, Sumi Y. Detection of melatonin and serotonin N-acetyltransferase and hydroxyindole-O-methyltransferase activities in rat ovary. Mol Cell Endocrinol 1997; 136: 7-13
13. Kadva A, Djahanbakach O, Monson J, Di WL, Silman R. Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic ammenorrhea. J Clin Endocrinol Metab 1998; 83: 3653-3662
14. Kovacs J, Brodner W, Kirchlechner V, Arif T, Waldhauser F. Measurement of urinary melatonin: A useful tool for monitoring serum melatonin after its administration. J Clin Endocrinol Metab 2000; 85: 666-670
15. Leibenluft E, Schmidt PJ, Turner EH, Danaceau MA, Ashman SB, Wehr TA, Rubinow DR. Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin and prolactin secretion in men. J Clin Endocrinol Metab 1997; 82: 3203-3207
16. Luboshitzky R, Lavi S, Thuma I, Lavie P. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1996a; 81: 770-774
17. Luboshitzky R, Wagner O, Lavi S, Herer P, Lavie P. Decreased nocturnal melatonin secretion in patients with Klinefelter's syndrome. Clin Endocrinol 1996 b; 45: 749-754
18. Luboshitzky R, Dharan M, Goldman D, Herer P, Hiss Y, Lavie P. Seasonal variation of gonadotropin and gonadal steroid receptors in the human pineal gland. Brain Res Bull 1997; 44: 665-670
19. Luboshitzky R, Lavie P. Melatonin and sex hormones interrelationships - a review. J Pediatr Endocrinol Metab 1999; 12: 355-362
20. Luboshitzky R, Levi M, Shen-Orr Z, Blumenfeld Z, Herer P, Lavie P. Long-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal men. Hum Reprod 2000 a; 15: 60-65
21. Luboshitzky R, Shen-Orr Z, Ishai A, Lavie P. Melatonin hypersecretion in male patients with adult-onset idiopathic hypogonadotropic hypogonadism. Exp Clin Endocrinol Diabetes 2000 b; 108: 142-145
22. Luboshitzky R, Shen-Orr Z, Nave R, Lavi S, Lavie P. Melatonin administration alters semen quality in healthy man. J Androl 2002; 23: 547-554
23. Mathews CD, Guerin MV, Wang X. Human plasma melatonin and urinary 6-sulphatoxymelatonin: studies in natural animal photoperiod and in extended darkness. Clin Endocrinol 1991; 35: 21-27
24. Okatani Y, Sagara Y. Amplification of melatonin secretion in women with functional secondary ammenorrhea: relation to endogenous oestrogen concentration. Clin Endocrinol 1994; 41: 766-780
25. Oriola J, Plesa O, Machuca I, Pavia C, Rivera-Fillat F. Rapid screening method for detecting mutations in the 21 hydroxylase gene. Clin Chem 1997; 43: 557-561
26. Ozata M, Bulkur M, Bingal N, Beyhan Z, Corakci A, Bolu E, Gundogan MD. Daytime plasma melatonin levels in male hypogonadism. J Clin Endocrinol Metab 1996; 81: 1877-1881
27. Paoletti AM, Cagnacci A, Orru M, Ajossa S, Gueriero S, Melis GB. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. Fertil Steril 1999; 72: 448-453
28. Rajmil O, Puig-Domingo M, Tortosa F, Viader M, Patterson AG, Schwarzstein D, DeLeiva A. Melatonin concentration before and during testosterone replacement in primary hypogonadic men. Eur J Endocrinol 1997; 137: 48-52
29. Rittmaster RS. Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28: 409-421
30. San Martin A, Bogdan A, Touitou Y. Day-night differences in the effects of gonadal hormones on melatonin release from perifused rat pineals. Evidence of a circadian control. Steroids 1996; 61: 27-32
31. Shurtz EG, Brimer C, Shuetz JD. Environmental xenobiotics and the antihormone cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharamacol 1998; 54: 1113-1117
32. Skene DJ, Papagiannidou E, Hashemi E, Snelling J, Lewis DF, Fernandez M, Joannides C. Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. J Pineal Res 2001; 31: 333-342
33. Stefukj J, Hortner M, Ghosh M, Schauenstein K, Rinner I, Wolfler A, Semmler J, Liebmann PM. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat. J Pineal Res 2001; 30: 243-247
34. Ursing C, Hartter S, Von Bahr C, Tybring G, Bertilsson L, Rojmarl K. Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in men?. J Clin Invest 2002; 25: 459-462
35. Venturoli S, Marescalchi O, Colombo FM, Marcelli S, Ravaioli B, Bagnoli A, Paradisi R, Flamigni C. A prospective study randomized trial comparing low dose Flutamide, Finesteride, Ketoconazole, and Cyproterone Acetate-Estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999; 84: 1304-1310
36. Voordouw BGG, Euser R, Verdonk RER, Alberda BJ, DeJong FH, Drojendijk AC, Fauser BC, Cohen M. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 1992; 74: 108-117
37. Waldhauser F, Frisch H, Krautgasser GA, Sparotti A, Schober E, Bieglmayer C. Serum melatonin is not affected by glucocorticoids replacement in congenital adrenal hyperplasia. Acta Endocr 1986; 111: 355-359
38. Waldhauser F, Boepple PA, Schemper M, Mansfield MJ, Crowley WF. Serum melatonin in central precocious puberty is lower than age-matched prepubertal children. J Clin Endocrinol Metab 1991; 73: 793-796
39. Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediat 1998; 87: 159-164
40. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291
41. Woo MMM, Tai CJ, Kang SK, Nathwani PS, Pang SF, Leung PCK. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 2001: 86: 4789-4797
42. Yie SM, Niles LP, Younglai EV. Melatonin receptors on human granulosa cell membranes. J Clin Endocrinol Metab 1995; 80: 1747-1749